Sensors 2013, 13(3), 3625-3634; doi:10.3390/s130303625
Article

Fluorescent Imaging for Assessment of the Effect of Combined Application of Electroporation and Rifampicin on HaCaT Cells as a New Therapeutic Approach for Psoriasis

1 Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad.G. Bonchev Str., bl. 21, Sofia 1113, Bulgaria 2 Medical Faculty, Trakia University, 11 Armeiska Str., Stara Zagora 6000, Bulgaria 3 Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan 4 Medical Faculty, Sofia University, 1 Koziak Str., Sofia 1407, Bulgaria These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 11 January 2013; in revised form: 13 February 2013 / Accepted: 6 March 2013 / Published: 14 March 2013
(This article belongs to the Special Issue Medical & Biological Imaging)
PDF Full-text Download PDF Full-Text [637 KB, uploaded 14 March 2013 11:16 CET]
Abstract: The study aimed to clarify the role of electric pulses in combination with chemotherapy on the viability of keratinocyte cell line HaCaT, in the context of its application as a new therapeutic approach for psoriasis. The data show that electroporation of HaCaT cells in combination with rifampicin induces cytoskeleton disruption and increases permeability of cell monolayer due to cell-cell junctions’ interruption, visualized by fluorescent imaging of E-cadherin and actin integrity. This was accompanied with synergistic reduction of cell viability. The study proposes a new opportunity for more effective skin treatment than chemotherapy. The future application of this electrochemotherapeutic approach for combined local treatment of psoriasis may have serous benefits because of a high possibility to avoid side-effects of conventional chemotherapy.
Keywords: fluorescent imaging; electroporation; electrochemotherapy; rifampicin; psoriasis

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Nikolova, B.; Kostadinova, A.; Dimitrov, B.; Zhelev, Z.; Bakalova, R.; Aoki, I.; Saga, T.; Tsoneva, I. Fluorescent Imaging for Assessment of the Effect of Combined Application of Electroporation and Rifampicin on HaCaT Cells as a New Therapeutic Approach for Psoriasis. Sensors 2013, 13, 3625-3634.

AMA Style

Nikolova B, Kostadinova A, Dimitrov B, Zhelev Z, Bakalova R, Aoki I, Saga T, Tsoneva I. Fluorescent Imaging for Assessment of the Effect of Combined Application of Electroporation and Rifampicin on HaCaT Cells as a New Therapeutic Approach for Psoriasis. Sensors. 2013; 13(3):3625-3634.

Chicago/Turabian Style

Nikolova, Biliana; Kostadinova, Anelia; Dimitrov, Borislav; Zhelev, Zhivko; Bakalova, Rumiana; Aoki, Ichio; Saga, Tsuneo; Tsoneva, Iana. 2013. "Fluorescent Imaging for Assessment of the Effect of Combined Application of Electroporation and Rifampicin on HaCaT Cells as a New Therapeutic Approach for Psoriasis." Sensors 13, no. 3: 3625-3634.

Sensors EISSN 1424-8220 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert